‘The role of Ozempic isn’t just about reduced consumption, it’s about a shift in values’

The Drinks Business is reporting on how GLP-1 medications like Ozempic are quietly reshaping UK drinking habits, with consumers opting for lower-calorie, lower-sugar options when they do drink. According to DrinkWell's founder, this signals a broader shift towards health-conscious choices rather than abstinence – which means the wine and spirits industry needs to innovate faster on the wellness front or risk being left behind like they were with soft drinks.